External Mastalgia-oil Versus Oral Tamoxifen in Premenopausal Women with Severe Mastalgia

Phase 3 Not yet recruiting 456 enrolled Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University

RandomizedParallel-groupQuadruple-blindTreatment

Summary

This is a single-center, double-blind, double-simulated, positive-controlled, randomized clinical trial to explore the efficacy and safety of external mastalgia-oil versus oral tamoxifen in premenopausal women with severe mastalgia.

Timeline

Start: 2025-01-16
Primary completion: 2029-01-16
Completion: 2030-05-16

Publications

Background Kumar S, Rai R, Das V, Kumar S, Dwivedi V, Agrawal GG. Visual analogue scale for assessing breast nodularity in non-discrete lumpy breasts: the Lucknow-Cardiff breast nodularity scale. Breast. 2010 Jun;19(3):238-42. doi: 10.1016/j.breast.2010.02.002. Epub 2010 Mar 11.

Drugs

Evaluation	Drug	Modality	Dose	Route
Comparator	Tamoxifen	Small molecule	10 mg	Oral
Subject	mastalgia-oil	Unknown	1 ml	Other

Indications

No indication recorded.